Assembly Biosciences (ASMB) Other financing activities (2010 - 2018)
Assembly Biosciences (ASMB) recorded quarterly Other financing activities of -$543780.0 in Q3 2018, down 2983.7% quarter-over-quarter from $18857.0 in Q2 2018, and down 451.84% on a YoY basis from $154552.1 in Q3 2017.
Assembly Biosciences (ASMB) Other financing activities (2010 - 2018) Analysis & Trends
Assembly Biosciences' Other financing activities history runs 6 years deep, the most recent figure standing at -$543780.0 for Q3 2018.
- In Q3 2018, Other financing activities fell 451.84% year-over-year to -$543780.0; the TTM figure through Sep 2018 stood at -$524726.0 (down 138.03% YoY), while the FY2017 annual figure was -$84192.0, down 44.64% from the prior year.
- Other financing activities was -$543780.0 for Q3 2018 at Assembly Biosciences, down from $18857.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $86231.0 in Q4 2017 to a low of -$543780.0 in Q3 2018.
- Historically, Other financing activities has averaged -$63494.7 across 4 years, with a median of -$27032.0 in 2015.
- The sharpest annual moves came in 2017 and 2018: Other financing activities surged 293.32% in 2017, then plunged 724.97% in 2018.
- A 4-year view of Other financing activities shows it stood at -$27032.0 in 2015, then plunged by 85.05% to -$50022.0 in 2016, then jumped by 272.39% to $86231.0 in 2017, then tumbled by 730.61% to -$543780.0 in 2018.
- The last three Other financing activities figures came in at -$543780.0 (Q3 2018), $18857.0 (Q2 2018), and -$86034.0 (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -543,780.00 |
| Sep 30, 2018 | -543,780.00 |
| Jun 30, 2018 | 18,857.00 |
| Jun 30, 2018 | 18,857.00 |
| Mar 31, 2018 | -86,034.00 |
| Mar 31, 2018 | -86,034.00 |
| Dec 31, 2017 | 86,231.00 |
| Dec 31, 2017 | 86,231.00 |
| Sep 30, 2017 | -98,539.00 |
| Sep 30, 2017 | -98,539.00 |
| Jun 30, 2017 | -85,650.00 |
| Jun 30, 2017 | -85,650.00 |
| Mar 31, 2017 | 13,766.00 |
| Mar 31, 2017 | 13,766.00 |
| Dec 31, 2016 | -50,022.00 |
| Dec 31, 2016 | -50,022.00 |
| Sep 30, 2016 | -21,646.00 |
| Sep 30, 2016 | -21,646.00 |
| Jun 30, 2016 | 20,581.00 |
| Jun 30, 2016 | 20,581.00 |